Published in J Clin Invest on February 01, 1990
Regulation of intrarenal angiotensin II in hypertension. Hypertension (2002) 3.34
Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol (2001) 3.23
Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension (2003) 2.99
AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension (2004) 2.86
Intratubular renin-angiotensin system in hypertension. Hypertension (2011) 2.14
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest (1990) 1.99
Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension (2003) 1.89
Renin expression in renal proximal tubule. J Clin Invest (1993) 1.74
Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens (2012) 1.74
Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats. Hypertension (2010) 1.67
Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens (2010) 1.60
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest (1996) 1.59
Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases. Am J Hypertens (2006) 1.46
Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45
Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci (2009) 1.43
Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun (2004) 1.41
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther (2009) 1.19
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol (1999) 1.19
Intrarenal angiotensin II levels in normal and hypertensive states. J Renin Angiotensin Aldosterone Syst (2001) 1.18
Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens (2010) 1.18
The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol (2008) 1.15
Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity. Am J Nephrol (2010) 1.13
Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest (1995) 1.11
Endogenous production of angiotensin II modulates rat proximal tubule transport. J Clin Invest (1996) 1.11
Renal renin-angiotensin system. Contrib Nephrol (2004) 1.09
Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy. J Investig Med (2013) 1.09
Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J (2012) 1.08
Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci (2012) 1.08
Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol (2010) 1.06
Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest (1996) 1.04
IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol (2009) 1.03
Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway. Antioxid Redox Signal (2012) 1.01
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97
Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest (1992) 0.96
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig (2011) 0.95
Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells. Mol Cell Endocrinol (2009) 0.93
Renin and renin mRNA in proximal tubules of the rat kidney. J Clin Invest (1994) 0.92
Renin-angiotensin system in the kidney: What is new? World J Nephrol (2014) 0.92
An androgen-inducible proximal tubule-specific Cre recombinase transgenic model. Am J Physiol Renal Physiol (2008) 0.92
Classical Renin-Angiotensin system in kidney physiology. Compr Physiol (2014) 0.92
Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens (2012) 0.92
The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys. Int J Mol Sci (2012) 0.89
Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension (2011) 0.87
Endogenous angiotensin II modulates rat proximal tubule transport with acute changes in extracellular volume. Am J Physiol (1998) 0.85
Angiotensin II blockade and renal protection. Curr Pharm Des (2013) 0.85
Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med (2012) 0.85
The Sry3 Y chromosome locus elevates blood pressure and renin-angiotensin system indexes. Gend Med (2011) 0.84
Effect of prenatal dexamethasone on postnatal serum and urinary angiotensin II levels. Am J Hypertens (2010) 0.84
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease. Transl Res (2009) 0.83
Role of the intrarenal renin-angiotensin system in the progression of renal disease. Pediatr Nephrol (2016) 0.82
Interstitial fibroblast-like cells express renin-angiotensin system components in a fibrosing murine kidney. Am J Pathol (2002) 0.81
Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension. Physiol Rep (2016) 0.81
JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation. JAKSTAT (2012) 0.81
Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease. Int Rev Thromb (2011) 0.80
Identification of cis-regulatory sequences in the human angiotensinogen gene by transgene coplacement and site-specific recombination. Mol Cell Biol (2005) 0.79
Intratubular Renin-Angiotensin System in Hypertension. Curr Hypertens Rev (2006) 0.78
Determination of an angiotensin II-regulated proteome in primary human kidney cells by stable isotope labeling of amino acids in cell culture (SILAC). J Biol Chem (2013) 0.78
Urinary angiotensinogen as a biomarker of nephropathy in childhood. Int J Nephrol (2011) 0.78
Relationship between blood pressure variability and renal activity of the renin-angiotensin system. J Hum Hypertens (2015) 0.78
Luminal angiotensin II stimulates rat medullary thick ascending limb chloride transport in the presence of basolateral norepinephrine. Am J Physiol Renal Physiol (2015) 0.77
Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update. J Am Soc Nephrol (2017) 0.77
Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats. Am J Physiol Renal Physiol (2016) 0.76
Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans. Int J Biol Sci (2014) 0.75
Macrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells. Am J Physiol Renal Physiol (2016) 0.75
Intrarenal renin-angiotensin system activation in end-stage renal disease. Hypertens Res (2017) 0.75
Effect of luminal angiotensin II receptor antagonists on proximal tubule transport. Am J Hypertens (1999) 0.75
Urinary Angiotensinogen: A Promising Biomarker of AKI Progression in Acute Decompensated Heart Failure: What Does It Mean? Clin J Am Soc Nephrol (2016) 0.75
Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients. Int J Mol Sci (2016) 0.75
Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatr Nephrol (2014) 0.75
HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference. Biol Sex Differ (2017) 0.75
Circulating and tissue angiotensin systems. J Clin Invest (1987) 2.16
Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest (1984) 1.93
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest (1986) 1.73
Tubular transport responses to angiotensin. Am J Physiol (1985) 1.63
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int (1981) 1.62
Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A (1986) 1.62
Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res (1983) 1.62
Tissue and gene specificity of mouse renin expression. Hypertension (1984) 1.53
Angiotensin II: a potent regulator of acidification in the rat early proximal convoluted tubule. J Clin Invest (1987) 1.46
Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest (1989) 1.42
A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology (1987) 1.33
Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension (1986) 1.30
Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension (1986) 1.29
Renin and angiotensinogen gene expression in maturing rat kidney. Am J Physiol (1988) 1.26
Localization and properties of angiotensin receptors. J Hypertens (1985) 1.15
Renin expression by vascular endothelial cells in culture. Circ Res (1985) 1.14
Immunocytochemistry of the renin-angiotensin system: renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews. Kidney Int Suppl (1982) 1.14
Changes in single nephron renin release are mediated by tubular fluid flow rate. Kidney Int (1986) 1.00
Renin substrate in granules from rat kidney cortex. Biochem J (1976) 0.99
In situ hybridization histochemical detection of neuropeptide mRNA using DNA and RNA probes. Methods Enzymol (1989) 0.96
Ultrastructural immunocytochemical localization of renin and angiotensin II in the juxtaglomerular cells of the ischemic kidney in experimental renal hypertension. Am J Pathol (1984) 0.87
Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues. J Cardiovasc Pharmacol (1986) 0.86
[Hybridization in situ: methodology and applications to the analysis of phenomena of gene expression in endocrine glands and the nervous system]. Ann Endocrinol (Paris) (1985) 0.84
Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell (1991) 9.99
The emerging concept of vascular remodeling. N Engl J Med (1994) 4.27
Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med (1983) 3.63
Characterization of human prorenin expressed in mammalian cells from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.60
High-throughput genotyping with single nucleotide polymorphisms. Genome Res (2001) 3.55
Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA (2001) 3.38
Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res (2001) 2.98
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature (1995) 2.51
Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med (1997) 2.44
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35
Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol (1992) 2.20
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A (1995) 2.14
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest (1992) 2.13
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest (1989) 2.10
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest (1990) 2.07
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A (1993) 1.94
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem (1993) 1.87
Further defining housekeeping, or "maintenance," genes Focus on "A compendium of gene expression in normal human tissues". Physiol Genomics (2001) 1.85
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet (2010) 1.83
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A (1995) 1.82
Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation (1994) 1.79
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A (1997) 1.78
Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol (2000) 1.73
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest (1995) 1.71
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A (1995) 1.71
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest (1993) 1.66
Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A (1996) 1.61
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension (1999) 1.60
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 1.55
Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest (2000) 1.53
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet (1999) 1.53
Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol (1997) 1.52
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation (1996) 1.51
The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens (1999) 1.51
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest (1994) 1.48
Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation (1998) 1.46
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res (1991) 1.43
Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest (1989) 1.42
Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem (1997) 1.41
Significance of the vascular renin-angiotensin pathway. Hypertension (1986) 1.40
Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun (1992) 1.37
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest (1998) 1.37
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem (1999) 1.33
Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest (1993) 1.33
A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology (1987) 1.33
Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension (1989) 1.31
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest (1990) 1.31
Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol (1987) 1.29
Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension (1986) 1.29
A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res (1995) 1.23
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation (1993) 1.22
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg (2001) 1.21
Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest (1993) 1.17
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension (1992) 1.16
LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression. Proc Natl Acad Sci U S A (2000) 1.15
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest (1999) 1.15
Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res (1999) 1.15
Renin expression by vascular endothelial cells in culture. Circ Res (1985) 1.14
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest (1994) 1.13
Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest (1993) 1.10
Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes. Proc Natl Acad Sci U S A (1989) 1.09
Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest (1994) 1.09
Identification of negative and positive regulatory elements in the human renin gene. J Biol Chem (1989) 1.09
Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomical mapping system. Pacing Clin Electrophysiol (1998) 1.05
Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr Opin Neurobiol (1998) 1.05
Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci U S A (1995) 1.05
Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest (1991) 1.04
Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res (1987) 1.03
Molecular mechanism of tissue-specific regulation of mouse renin gene expression by cAMP. Identification of an inhibitory protein that binds nuclear transcriptional factor. J Biol Chem (1991) 1.03
Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry (1984) 1.01
Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor. J Clin Invest (1989) 1.01
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. Circulation (1997) 0.99
Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol (1984) 0.99
Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest (1996) 0.99
Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats. Res Commun Chem Pathol Pharmacol (1977) 0.98
A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. J Clin Invest (1999) 0.97
Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes. Proc Natl Acad Sci U S A (1992) 0.97
Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther (2003) 0.97
Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol (2001) 0.97
Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun (1994) 0.96
Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. J Clin Invest (1994) 0.96
The feedback regulation of angiotensinogen production by components of the renin-angiotensin system. Circ Res (1983) 0.96